Copyright Reports & Markets. All rights reserved.

Global RNA-Based Therapeutics and Vaccines Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global RNA-Based Therapeutics and Vaccines Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 RNA-Based Therapeutics
      • 1.4.3 RNA-Based Vaccines
    • 1.5 Market by Application
      • 1.5.1 Global RNA-Based Therapeutics and Vaccines Market Share by Application (2014-2025)
      • 1.5.2 Oncology
      • 1.5.3 Immunology
      • 1.5.4 Ophthalmology
      • 1.5.5 Cardiovascular Diseases
      • 1.5.6 Infectious Diseases
      • 1.5.7 Genetic Diseases
      • 1.5.8 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 RNA-Based Therapeutics and Vaccines Market Size
    • 2.2 RNA-Based Therapeutics and Vaccines Growth Trends by Regions
      • 2.2.1 RNA-Based Therapeutics and Vaccines Market Size by Regions (2014-2025)
      • 2.2.2 RNA-Based Therapeutics and Vaccines Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 RNA-Based Therapeutics and Vaccines Market Size by Manufacturers
      • 3.1.1 Global RNA-Based Therapeutics and Vaccines Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global RNA-Based Therapeutics and Vaccines Market Concentration Ratio (CR5 and HHI)
    • 3.2 RNA-Based Therapeutics and Vaccines Key Players Head office and Area Served
    • 3.3 Key Players RNA-Based Therapeutics and Vaccines Product/Solution/Service
    • 3.4 Date of Enter into RNA-Based Therapeutics and Vaccines Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global RNA-Based Therapeutics and Vaccines Market Size by Type (2014-2019)
    • 4.2 Global RNA-Based Therapeutics and Vaccines Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States RNA-Based Therapeutics and Vaccines Market Size (2014-2019)
    • 5.2 RNA-Based Therapeutics and Vaccines Key Players in United States
    • 5.3 United States RNA-Based Therapeutics and Vaccines Market Size by Type
    • 5.4 United States RNA-Based Therapeutics and Vaccines Market Size by Application

    6 Europe

    • 6.1 Europe RNA-Based Therapeutics and Vaccines Market Size (2014-2019)
    • 6.2 RNA-Based Therapeutics and Vaccines Key Players in Europe
    • 6.3 Europe RNA-Based Therapeutics and Vaccines Market Size by Type
    • 6.4 Europe RNA-Based Therapeutics and Vaccines Market Size by Application

    7 China

    • 7.1 China RNA-Based Therapeutics and Vaccines Market Size (2014-2019)
    • 7.2 RNA-Based Therapeutics and Vaccines Key Players in China
    • 7.3 China RNA-Based Therapeutics and Vaccines Market Size by Type
    • 7.4 China RNA-Based Therapeutics and Vaccines Market Size by Application

    8 Japan

    • 8.1 Japan RNA-Based Therapeutics and Vaccines Market Size (2014-2019)
    • 8.2 RNA-Based Therapeutics and Vaccines Key Players in Japan
    • 8.3 Japan RNA-Based Therapeutics and Vaccines Market Size by Type
    • 8.4 Japan RNA-Based Therapeutics and Vaccines Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia RNA-Based Therapeutics and Vaccines Market Size (2014-2019)
    • 9.2 RNA-Based Therapeutics and Vaccines Key Players in Southeast Asia
    • 9.3 Southeast Asia RNA-Based Therapeutics and Vaccines Market Size by Type
    • 9.4 Southeast Asia RNA-Based Therapeutics and Vaccines Market Size by Application

    10 India

    • 10.1 India RNA-Based Therapeutics and Vaccines Market Size (2014-2019)
    • 10.2 RNA-Based Therapeutics and Vaccines Key Players in India
    • 10.3 India RNA-Based Therapeutics and Vaccines Market Size by Type
    • 10.4 India RNA-Based Therapeutics and Vaccines Market Size by Application

    11 Central & South America

    • 11.1 Central & South America RNA-Based Therapeutics and Vaccines Market Size (2014-2019)
    • 11.2 RNA-Based Therapeutics and Vaccines Key Players in Central & South America
    • 11.3 Central & South America RNA-Based Therapeutics and Vaccines Market Size by Type
    • 11.4 Central & South America RNA-Based Therapeutics and Vaccines Market Size by Application

    12 International Players Profiles

    • 12.1 Alnylam Pharmaceuticals
      • 12.1.1 Alnylam Pharmaceuticals Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 RNA-Based Therapeutics and Vaccines Introduction
      • 12.1.4 Alnylam Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2014-2019)
      • 12.1.5 Alnylam Pharmaceuticals Recent Development
    • 12.2 Arbutus Biopharma
      • 12.2.1 Arbutus Biopharma Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 RNA-Based Therapeutics and Vaccines Introduction
      • 12.2.4 Arbutus Biopharma Revenue in RNA-Based Therapeutics and Vaccines Business (2014-2019)
      • 12.2.5 Arbutus Biopharma Recent Development
    • 12.3 Arrowhead Pharmaceuticals
      • 12.3.1 Arrowhead Pharmaceuticals Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 RNA-Based Therapeutics and Vaccines Introduction
      • 12.3.4 Arrowhead Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2014-2019)
      • 12.3.5 Arrowhead Pharmaceuticals Recent Development
    • 12.4 BioNTech
      • 12.4.1 BioNTech Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 RNA-Based Therapeutics and Vaccines Introduction
      • 12.4.4 BioNTech Revenue in RNA-Based Therapeutics and Vaccines Business (2014-2019)
      • 12.4.5 BioNTech Recent Development
    • 12.5 CureVac
      • 12.5.1 CureVac Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 RNA-Based Therapeutics and Vaccines Introduction
      • 12.5.4 CureVac Revenue in RNA-Based Therapeutics and Vaccines Business (2014-2019)
      • 12.5.5 CureVac Recent Development
    • 12.6 Dicerna Pharmaceuticals
      • 12.6.1 Dicerna Pharmaceuticals Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 RNA-Based Therapeutics and Vaccines Introduction
      • 12.6.4 Dicerna Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2014-2019)
      • 12.6.5 Dicerna Pharmaceuticals Recent Development
    • 12.7 Regulus Therapeutics
      • 12.7.1 Regulus Therapeutics Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 RNA-Based Therapeutics and Vaccines Introduction
      • 12.7.4 Regulus Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2014-2019)
      • 12.7.5 Regulus Therapeutics Recent Development
    • 12.8 Marina Biotech
      • 12.8.1 Marina Biotech Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 RNA-Based Therapeutics and Vaccines Introduction
      • 12.8.4 Marina Biotech Revenue in RNA-Based Therapeutics and Vaccines Business (2014-2019)
      • 12.8.5 Marina Biotech Recent Development
    • 12.9 MiRagen Therapeutics
      • 12.9.1 MiRagen Therapeutics Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 RNA-Based Therapeutics and Vaccines Introduction
      • 12.9.4 MiRagen Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2014-2019)
      • 12.9.5 MiRagen Therapeutics Recent Development
    • 12.10 Moderna Therapeutics
      • 12.10.1 Moderna Therapeutics Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 RNA-Based Therapeutics and Vaccines Introduction
      • 12.10.4 Moderna Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2014-2019)
      • 12.10.5 Moderna Therapeutics Recent Development
    • 12.11 Quark Pharmaceuticals
    • 12.12 Roche
    • 12.13 Sylentis

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      RNA-based biopharmaceuticals, which includes therapeutics and vaccines, is a relatively new class of treatment and prophylactic for a number of chronic and rare diseases, including cancer, diabetes, tuberculosis and certaincardiovascular conditions.
      RNA-based biopharmaceuticals are a relatively new class of therapies that are demonstrating significant growth and potential for the treatment and prevention of chronic and rare diseases.
      In 2018, the global RNA-Based Therapeutics and Vaccines market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global RNA-Based Therapeutics and Vaccines status, future forecast, growth opportunity, key market and key players. The study objectives are to present the RNA-Based Therapeutics and Vaccines development in United States, Europe and China.

      The key players covered in this study
      Alnylam Pharmaceuticals
      Arbutus Biopharma
      Arrowhead Pharmaceuticals
      BioNTech
      CureVac
      Dicerna Pharmaceuticals
      Regulus Therapeutics
      Marina Biotech
      MiRagen Therapeutics
      Moderna Therapeutics
      Quark Pharmaceuticals
      Roche
      Sylentis

      Market segment by Type, the product can be split into
      RNA-Based Therapeutics
      RNA-Based Vaccines

      Market segment by Application, split into
      Oncology
      Immunology
      Ophthalmology
      Cardiovascular Diseases
      Infectious Diseases
      Genetic Diseases
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global RNA-Based Therapeutics and Vaccines status, future forecast, growth opportunity, key market and key players.
      To present the RNA-Based Therapeutics and Vaccines development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of RNA-Based Therapeutics and Vaccines are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now